EMvision Medical Devices Ltd. (AU:EMV)
ASX:EMV
Want to see AU:EMV full AI Analyst Report?
EMV Stock Chart & Stats
AU$1.77
-AU$0.06(-3.19%)
At close: 4:00 PM EST
AU$1.77
-AU$0.06(-3.19%)
Day’s Range― - ―
52-Week RangeAU$1.48 - AU$2.43
Previous CloseN/A
Volume36.00K
Average Volume (3M)120.98K
Market Cap
AU$152.45M
Enterprise ValueAU$146.33M
Total Cash (Recent Filing)AU$17.56M
Total Debt (Recent Filing)AU$4.02M
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding92,955,560
10 Day Avg. Volume127,185
30 Day Avg. Volume120,982
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)16.01
Price to Sales (P/S)29.42
P/FCF Ratio-18.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$3.15Price Target Upside77.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.1
Revenue Forecast (FY)AU$5.50M
Bulls Say, Bears Say
Bulls Say
Point-of-care Imaging ProductEMvision’s focus on portable electromagnetic brain imaging for emergency and pre-hospital settings targets a durable structural need: faster bedside stroke/TBI detection. This product-led strategy can create lasting clinical adoption barriers if validated and integrated into emergency care workflows.
Moderate LeverageA debt-to-equity around 0.38 implies limited financial leverage, reducing insolvency risk and preserving flexibility to raise capital for R&D or commercialization. Over months this helps sustain operations and funding options without excessive interest burden on future cash flows.
High Gross Margin ProfileA reported 100% gross margin implies strong unit economics at the product level. If sustained with scale, such margins create room to cover fixed R&D and SG&A, enabling profitability as revenue grows and improving long-term return potential once operating losses are reduced.
Bears Say
Declining RevenuesA >30% year decline in revenue is a durable red flag for commercial traction. Falling top-line reduces ability to leverage fixed costs, lengthens breakeven timelines, increases financing needs, and signals challenges in customer adoption or market penetration over the next several months.
Negative Operating And Free Cash FlowPersistent negative operating and free cash flows indicate the business burns cash to run and develop products. This creates reliance on external funding, limits ability to invest in commercialization, and raises risk of dilution or constrained execution over a multi-month horizon.
Persistent Losses And Weak ReturnsOngoing negative profitability and ROE show the company is not generating shareholder returns from current operations. Without improving margins or revenue growth, persistent losses will depress equity value and impede reinvestment capacity, a structural concern for durability.
EMvision Medical Devices Ltd. News
EMV FAQ
What was EMvision Medical Devices Ltd.’s price range in the past 12 months?
EMvision Medical Devices Ltd. lowest share price was AU$1.48 and its highest was AU$2.43 in the past 12 months.
What is EMvision Medical Devices Ltd.’s market cap?
EMvision Medical Devices Ltd.’s market cap is AU$152.45M.
When is EMvision Medical Devices Ltd.’s upcoming earnings report date?
EMvision Medical Devices Ltd.’s upcoming earnings report date is Sep 02, 2026 which is in 84 days.
How were EMvision Medical Devices Ltd.’s earnings last quarter?
EMvision Medical Devices Ltd. released its earnings results on Feb 22, 2026. The company reported -AU$0.044 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.044.
Is EMvision Medical Devices Ltd. overvalued?
According to Wall Street analysts EMvision Medical Devices Ltd.’s price is currently Undervalued.
Does EMvision Medical Devices Ltd. pay dividends?
EMvision Medical Devices Ltd. does not currently pay dividends.
What is EMvision Medical Devices Ltd.’s EPS estimate?
EMvision Medical Devices Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EMvision Medical Devices Ltd. have?
EMvision Medical Devices Ltd. has 92,955,560 shares outstanding.
What happened to EMvision Medical Devices Ltd.’s price movement after its last earnings report?
EMvision Medical Devices Ltd. reported an EPS of -AU$0.044 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of EMvision Medical Devices Ltd.?
Currently, no hedge funds are holding shares in AU:EMV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EMvision Medical Devices Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$3.15 (77.97% Upside)
AU$3.15 (77.97% Upside)
Blogger Sentiment
Bullish
AU:EMV Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$18.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.44%
12-Months-Change
Fundamentals
Return on Equity
-70.29%
Trailing 12-Months
Asset Growth
25.56%
Trailing 12-Months
Company Description
EMvision Medical Devices Ltd.
EMVision Medical Devices Limited is an Australian enterprise specializing in the innovation, development, and market introduction of advanced imaging and diagnostic healthcare technologies. The company's principal offering is a compact, mobile brain scanner engineered for the swift detection and continuous tracking of strokes, in addition to fulfilling other medical imaging necessities. Founded in 2017, its operations are headquartered in Macquarie Park.
EMV Stock 12 Month Forecast
Average Price Target
AU$3.15
▲(77.97% Upside)
Technical Analysis
Compumedics Limited
―
Impedimed Limited
―
Cyclopharm Limited
―
Aroa Biosurgery Ltd
―
4DMedical Ltd
―
Options Prices
Currently, No data available
---